Inhibition of DLX6 sensitizes lung adenocarcinoma to cisplatin via GPX4-dependent ferroptosis
Cellular Oncology · 2026
DOI: 10.1007/s13402-026-01263-w ↗Kurz gefasst
Fachartikel in der Zeitschrift Cellular Oncology, 2026. Verfasst von Zedong Sun und 10 weiteren Autor:innen. Beteiligte Einrichtung: Department of Thoracic Surgery, Nanjing Medical University Affiliated Cancer Hospital & Jiangsu Cancer Hospital & Jiangsu Institute of Cancer Researc…. Hauptthemen laut MEDLINE: Ferroptosis, Cisplatin, Homeodomain Proteins, Adenocarcinoma of Lung. Die Arbeit nennt 42 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC-ND 4.0). Gefördert von: National Natural Science Foundation of China, Youth Cultivation Funding of the First Affiliated Hospital of Hainan Medical University, Jiangsu Province Capability Improvement Project through Science, Technology and Education, Jiangsu Provincial Medical Innovation Center.
Abstract (Originalsprache)
Kein Abstract verfügbar.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Department of Thoracic Surgery, Nanjing Medical University Affiliated Cancer Hospital & Jiangsu Cancer Hospital & Jiangsu Institute of Cancer Research, Nanjing, People's Republic of China.
- Jiangsu Key Laboratory of Innovative Cancer Diagnosis & Therapeutics, Cancer Institute of Jiangsu Province, Nanjing, People's Republic of China.
- The Fourth Clinical College of Nanjing Medical University, Nanjing, People's Republic of China.
- China Pharmaceutical University, Nanjing, People's Republic of China.
- Department of Thoracic Surgery, Jiangsu Key Laboratory of Innovative Cancer Diagnosis & Therapeutics, Nanjing Medical University Affiliated Cancer Hospital & Jiangsu Cancer Hospital & Jiangsu Institute of Cancer Researc…
- Department of Pharmacy and Engineering Research Center of Tropical Medicine Innovation and Transformation, Key Laboratory of Emergency and Trauma of Ministry of Education, The First Affiliated Hospital, Hainan Medical U…
ORCID-Profile: Binhui Ren
Förderung
- National Natural Science Foundation of China
- Youth Cultivation Funding of the First Affiliated Hospital of Hainan Medical University
- Jiangsu Province Capability Improvement Project through Science, Technology and Education, Jiangsu Provincial Medical Innovation Center
Zitieren
APA
Sun, Z., Zhou, M., Wang, C., Liu, M., Song, N., He, S., Ji, F., Chen, J., Xu, L., Zheng, X., & Ren, B. (2026). Inhibition of DLX6 sensitizes lung adenocarcinoma to cisplatin via GPX4-dependent ferroptosis. Cellular Oncology. https://doi.org/10.1007/s13402-026-01263-w
Vancouver
Sun Z, Zhou M, Wang C, Liu M, Song N, He S, et al. Inhibition of DLX6 sensitizes lung adenocarcinoma to cisplatin via GPX4-dependent ferroptosis. Cellular Oncology. 2026. doi:10.1007/s13402-026-01263-w
BibTeX
@article{Sun2026,
author = {Sun, Zedong and Zhou, Minmin and Wang, Can and Liu, Mingrui and Song, Ningdan and He, Simian and Ji, Feifan and Chen, Jiayu and Xu, Lin and Zheng, Xiufen and Ren, Binhui},
title = {Inhibition of DLX6 sensitizes lung adenocarcinoma to cisplatin via GPX4-dependent ferroptosis},
journal = {Cellular Oncology},
year = {2026},
doi = {10.1007/s13402-026-01263-w}
}
EUVIMED